|
May 27
|
Is UFP (UFPT) a Solid Growth Stock? 3 Reasons to Think "Yes"
|
|
May 23
|
Here's What To Make Of UFP Technologies' (NASDAQ:UFPT) Decelerating Rates Of Return
|
|
May 20
|
3 Hyped Up Stocks Facing Headwinds
|
|
May 20
|
Drug Development Inputs & Services Stocks Q1 Results: Benchmarking Charles River Laboratories (NYSE:CRL)
|
|
May 19
|
UFPT Q1 Earnings Call: Medical Segment Growth and Strategic Expansion Drive Outperformance
|
|
May 9
|
Results: UFP Technologies, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
|
|
Apr 10
|
BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know
|
|
Apr 10
|
Should You Think About Buying UFP Technologies, Inc. (NASDAQ:UFPT) Now?
|
|
Mar 14
|
Is UFP Technologies, Inc. (NASDAQ:UFPT) Trading At A 48% Discount?
|
|
Mar 13
|
Unpacking Q4 Earnings: UFP Technologies (NASDAQ:UFPT) In The Context Of Other Drug Development Inputs & Services Stocks
|
|
Mar 12
|
3 Small-Cap Stocks in Hot Water
|
|
Mar 12
|
3 Small-Cap Stocks Walking a Fine Line
|
|
Mar 12
|
Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks
|
|
Mar 2
|
What To Expect From Fortrea’s (FTRE) Q4 Earnings
|
|
Feb 28
|
UFP Technologies, Inc. (NASDAQ:UFPT) Full-Year Results: Here's What Analysts Are Forecasting For This Year
|
|
Feb 26
|
UFP Technologies Full Year 2024 Earnings: EPS Beats Expectations
|
|
Feb 25
|
Why UFP Technologies (UFPT) Stock Is Trading Up Today
|
|
Feb 25
|
UFP Technologies (NASDAQ:UFPT) Exceeds Q4 Expectations
|
|
Feb 25
|
UFP: Q4 Earnings Snapshot
|
|
Feb 25
|
UFP Technologies Announces Record 2024 Results
|